Research and development of digital diagnosis and treatment equipment and systems based on artificial intelligence

Research and development of personalized intelligent diagnosis and treatment system for pulmonary subsolid nodules based on growth law and multi-source omics

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300074133

Enrollment

Unknown

Registered

2023-07-31

Start date

2023-08-01

Completion date

Unknown

Last updated

2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary nodules

Interventions

cases with SSN infiltration:none

the prognosis of early lung adenocarcinoma with SSN type:none

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for cases with SSN infiltration: ? Patients with lung adenocarcinoma confirmed histologically by lung surgery; ? Thin-slice CT scan (thickness =1.5mm) was performed in all patients 1 month before surgery. ? The lesions in the pulmonary window showed SSN (including some solid nodules and pure ground glass nodules); ? No preoperative radiotherapy and chemotherapy, no history of distant metastasis and other malignant tumors. metastasis and other malignant tumors The inclusion criteria of early stage lung adenocarcinoma with SSN type were as follows: ? After complete surgical resection, the pathological results were lung adenocarcinoma; ? The lesions in the pulmonary window showed SSN (including some solid nodules and pure ground glass nodules); ? Thin-slice CT scan (layer thickness =1.5mm) was performed in all patients 1 month before surgery. ? Adequate follow-up data.

Exclusion criteria

Exclusion criteria: Exclusion criteria for cases of SSN infiltration: ? Biopsy, radiotherapy and chemotherapy before preoperative CT examination ? CT scan in low-dose mode ? The image has obvious artifacts and other cases of unqualified image quality The criteria to exclude the prognosis of early lung adenocarcinoma with SSN type were as follows: ? A history of thoracotomy with malignant tumor; ? Patients were treated with preoperative radiotherapy and chemotherapy or puncture; ? Postoperative non-tumor causes of death and loss of visitors; ?Lack of clinical or imaging data

Design outcomes

Primary

Measure	Time frame
Nodular growth;overall survival;	—

Secondary

Measure	Time frame
disease-free survival;	—

Countries

China

Contacts

Public ContactMaosheng Xu

The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine)

xums166@zcmu.edu.cn+86 136 0580 8040

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026